Figure 2.
The Sarcoma Multi-center Clinical Evaluation of the Efficacy of Ridaforolimus (SUCCEED) study scheme is shown. CR indicates complete response; PR, partial response; SD, stable disease; CT, chemotherapy.
The Sarcoma Multi-center Clinical Evaluation of the Efficacy of Ridaforolimus (SUCCEED) study scheme is shown. CR indicates complete response; PR, partial response; SD, stable disease; CT, chemotherapy.